Abiopharma

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Pasithea Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Vanda Pharmaceuticals Announces FDA Granted Orphan Drug Designation for VGT-1849B, a Novel and Selective Candidate for the Treatment of Polycythemia Vera

Rocket Pharmaceuticals to Participate in Upcoming Investor Conferences

Tonix Pharmaceuticals to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2025

MindMed to Participate in September Investor Conferences

Cibus Enters into Agreement with the Latin American Rice Hybrid Consortium to Provide Cibus’ Herbicide Tolerance Trait

Passage Bio, Inc. - Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Compugen to Present at the H.C. Wainwright 27th Annual Global Investment Conference

Tenax Therapeutics to Participate in the Cantor Global Healthcare Conference 2025

Akero Therapeutics to Present at the Morgan Stanley 23rd Annual Global Healthcare Conference

Tilray Medical Expands Presence in Germany with Introduction of New Good Supply Medical Cannabis Strains

Passage Bio to Participate in H.C. Wainwright 27th Annual Global Investment Conference

Cartesian Therapeutics to Participate in Upcoming Investor Conferences

Q32 Bio to Participate in the 2025 Wells Fargo Healthcare Conference